Effect of isradipine on endothelin-1 plasma concentrations in patients with Raynaud's phenomenon.
La Civita
L
L
Giuggioli
D
D
Del Chicca
M G
MG
Longombardo
G
G
Pasero
G
G
Ferri
C
C
D000328:Adult; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004311:Double-Blind Method; D016232:Endothelins / Q000097:blood*; D005260:Female; D006801:Humans; D017275:Isradipine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011928:Raynaud Disease / Q000097:blood* / Q000188:drug therapy; D014665:Vasodilator Agents / Q000627:therapeutic use*
D002121:Calcium Channel Blockers; D016232:Endothelins; D014665:Vasodilator Agents; D017275:Isradipine